ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exos...
Saved in:
Published in | Developmental cell Vol. 57; no. 3; pp. 329 - 343.e7 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
07.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.
[Display omitted]
•ICAM-1 and PD-L1 co-localize on exosomes and are both upregulated by interferon-γ•ICAM-1 is a prerequisite for exosomal PD-L1-mediated inhibition of CD8+ T cells•Reciprocal upregulation of ICAM-1 and LFA-1 promotes exosome-T cell interaction•Established an assay system for the interaction of exosomal PD-L1 with PD-1 on T cells
Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Wei Zhang and Wenqun Zhong contributed equally to this work. W.Z. and W.G. conceived the project and designed the experiments. W.Z., W.Zho., B.W., and Jie.Y. purified and characterized extracellular vesicles. W.Z., W.Zho., B.W., Jie.Y., Jin.Y. and Z.Y. performed the mice experiments. W.Z. and W.Zho. established knockdown and knockout cell lines, collected exosomes and performed the T cell binding assays, the T cell proliferation and activation assays. W.Z., W. Zho. and Z.Q. performed ELISA assays. W.Z., W. Zho. and B.W. performed the nanoparticle tracking analysis. W.Z., W. Zho., B.W., Jie.Y. and A.S. performed the immunoprecipitation and western blot analysis. W.Z. established EDITS system and tested the exosomal PD-L1/PD-1 interaction. W. Zho performed immune-TEM and ICAM-1+ exosome depletion assays. W.Z., W.Zho. and Jin. Y. performed the flow cytometry experiments. X.X. performed pathological analyses. W.X., C.Z., L.M.S., G.C.K., T.C.M. and R.A. provided human samples and associated clinical data. M.H., and H.D. provided antibodies and cell lines. W.Z., W.Zho., B.W., Jie.Y. analyzed and interpreted the data. W.Z. and P.A.G. performed the statistical analysis. W.Z., W.Zho. and W.G. wrote the paper. A.S., W.X., R.A. and X.X. edited the paper. All authors have read and approved the final manuscript. Lead contact Author contributions |
ISSN: | 1534-5807 1878-1551 1878-1551 |
DOI: | 10.1016/j.devcel.2022.01.002 |